System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Review Epublish 6 citations

PubMed: 40486456 DOI: 10.7759/cureus.83673

Role of Mobile Health and Wearable Devices in Cardiovascular Disease Prevention: A Comprehensive Review.

Cureus 17(5):e83673

Authors: Owais M Ahmad, Ruba Ibrahim, Daniella I Odunsi, Mahdi Mohammed, Bobby George Mathew, Mohamed Touny, Bhupinder S Grewal, Shubham Bhanot, Neeraj Bodapati, George Pandarakalam Thomas, Shreyas Nv, Lalain Masood, Zoya Morani

Affiliations

  • Internal Medicine, Charles University, Hradec Kralove, CZE.
  • Medicine and Surgery, University of Medical Sciences and Technology (UMST), Khartoum, SDN.
  • Internal Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, GBR.
  • School of Medicine, University College Dublin, Dublin, IRL.
  • Anaesthesia, Chris Hani Baragwanath Academic Hospital, Johannesburg, ZAF.
  • Cardiology, National Heart Institute, Giza, EGY.
  • Cardiovascular Service Line, Morristown Medical Center, Morristown, USA.
  • Acute Medicine, Cumberland Infirmary, Carlisle, GBR.
  • Internal Medicine, Alluri Sitarama Raju Academy of Medical Sciences, Eluru, IND.
  • Internal Medicine, Dorset County Hospital, Dorchester, GBR.
  • General Medicine, Shirdi Sai Hospital, Bengaluru, IND.
  • Dermatology, Bahria University Medical and Dental College, Karachi, PAK.
  • Family Medicine, Washington University of Health and Science, San Pedro, BLZ.

Abstract

Cardiovascular disease (CVD) is a leading cause of death worldwide. A key area of interest in CVD prevention is novel digital health technologies, primarily mobile health (mHealth) applications and wearable devices, that are rapidly transforming the methods of preventing and managing CVD. Studies have shown the success of smartphone applications, such as the RITMIA app (Heart Sentinelâ„¢, Parma, Italy), in successfully detecting atrial fibrillation (Afib) compared to a classic 12-lead electrocardiogram (ECG). mHealth devices should integrate these factors, based on artificial intelligence (AI) and driven by chatbots, to encourage patients to use technology through interactive, real-world, motivational, and timely feedback. Data from mHealth clinical research indicate improved medication adherence, weight control, and self-care among patients. This review highlights mHealth and wearable devices in CVD prevention, providing foresight into cardiovascular health conditions through continuous monitoring, early detection, and improved patient engagement. Additionally, it examines challenges, including ethical, regulatory, and accessibility issues, that need to be addressed before their widespread adoption. In the future, the priority must be integration with healthcare systems and equitable access. A thorough search was conducted using reputable databases such as Scopus, PubMed, and Google Scholar. Articles from 2015 to 2025, along with an article from 2002 published in reputable peer-reviewed journals, were analyzed and contextually used. We also refined our search terms and used high-quality English articles to achieve this.

MeSH

Cardiovascular Diseases, Smartphone, Wearable Electronic Devices, Artificial Intelligence, Digital Health

Cited by